CNS Pharmaceuticals (CNSP) Stock: Buy, Sell, or Hold?
CNSP - CNS Pharmaceuticals, Inc. Common Stock
$5.32
0.08 (1.61%)
▲
5d:
+7.99%
30d:
-11.4%
90d:
+6.92%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When CNSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNSP is currently trading at $5.32, which is considered slightly low relative to its 30-day fair value range of $5.17 to $5.85.
Technical Outlook: Technically, CNSP is in a uptrend. Immediate support is located at $4.91, while resistance sits at $5.50.
Market Sentiment: CNSP scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+87.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNSP is in a uptrend. Immediate support is located at $4.91, while resistance sits at $5.50.
Market Sentiment: CNSP scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+87.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$5.17 -
$5.85
Company Quality Score
70/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (86/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.8% below Wall St target ($10.00)
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$5.17 -
$5.85
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.91
Resistance Level
$5.50
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.21
Wall Street Target
$10.00
(+87.8%)
Share & Embed Analysis
Last updated: October 02, 2026 5:27 PM ET
Data refreshes hourly during market hours. Next update: 6:27 PM
Data refreshes hourly during market hours. Next update: 6:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
